BROOMFIELD, CO - January 28, 2025 (NEWMEDIAWIRE) - Aclarion, Inc., ("Aclarion ... revised timing and a revised split ratio for its pending reverse stock split of its common stock.

The reverse stock split will not change the authorized ... split shares outstanding as a result of the reverse stock split. About Aclarion, Inc. Aclarion is a healthcare technology company that ...

The decision for the reverse stock split came after stockholders approved an amendment to the company's Certificate of Incorporation on December 31, 2024. Aclarion's Board of Directors ...

The decision for the reverse stock split came after stockholders approved an amendment to the company's Certificate of Incorporation on December 31, 2024. Aclarion's Board of Directors subsequently ...

Aclarion , Inc. (NASDAQ:ACON), a medical laboratory services provider with a current market capitalization of just $0.29 million, has announced a reverse stock split of its common stock at a ratio ...

Aclarion's goal with the reverse stock split is to boost its common stock's per share and bid price above the $1.00 minimum required by Nasdaq. The company's common stock will be assigned a new ...

Additionally, Aclarion has announced a reverse stock split of its common stock at a ratio of 1-for-335, reducing the number of issued and outstanding shares from approximately 169.4 million to about ...